CD47 is a well-characterized immune evasion molecule in tumor biology, and its overexpression in therapeutic cells raises concerns about off-target effects, including interference with dendritic-cell-mediated antigen presentation and the inadvertent protection of residual tumor cells. The gene discussed is CD47; the disease is neoplasm.